Premier Perspectives The blog for insider insights in clinical development Recent Posts By expertise area All expertise areas Medical DeviceRare DiseaseOncology & HematologyDiagnosticsDigital TherapeuticsMedTechPediatricsNeuroscienceAnalgesiaDermatologyOtherCOVID-19Cell & Gene TherapyWomen's HealthReal-World & Late PhaseLife at Premier By functional area All functional areas Development StrategyClinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Clinical ResearchPhase 1 - Phase 4 4 Steps to Implementing DEI in Clinical Trial Design and Patient Recruitment By Stacy Weil January 18, 2024 Consulting Is Your In Vitro Diagnostic Exempt from Investigational Device Exemption Regulations? By Charles Chrisawn January 17, 2024 Clinical ResearchPhase 1 - Phase 4 FDA’s Push for DEI in Clinical Trials: What Sponsors Need to Know in 2024 By Stacy Weil January 11, 2024 Clinical ResearchPhase 1 - Phase 4 7 Reasons to Ditch Traditional Monitoring in Favor of a Centralized Strategy By Nicole Stansbury January 3, 2024 Clinical ResearchPhase 1 - Phase 4 Data at Your Fingertips: The Case for Centralized Monitoring By Nicole Stansbury December 14, 2023 Clinical ResearchPhase 1 - Phase 4 Patient-Centered Hematological Malignancy Trials: A Blueprint for Success By Ashley Herrick December 5, 2023 Previous 1 2 3 4 5 6 … 57 Next × ALSO OF INTERESTKey Considerations When Designing a Phase 1...Nostalgia or Shell Shock? Assessing PTSD Is a...Gene Therapy 101: From the 1960s to Today